ChemPartner PharmaTech Co
ChemPartner PharmaTech Co., a leading player in the pharmaceutical and biotechnology sectors, is headquartered in China (CN) and operates extensively across Asia, Europe, and North America. Founded in 2003, the company has established itself as a trusted partner in drug discovery, development, and manufacturing services, catering to a diverse clientele in the life sciences industry. With a robust portfolio that includes integrated drug discovery, preclinical development, and clinical trial services, ChemPartner stands out for its commitment to innovation and quality. The company’s state-of-the-art facilities and experienced team enable it to deliver tailored solutions that accelerate the drug development process. Recognised for its scientific expertise and operational excellence, ChemPartner has achieved significant milestones, solidifying its position as a preferred partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does ChemPartner PharmaTech Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ChemPartner PharmaTech Co's score of 24 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ChemPartner PharmaTech Co's reported carbon emissions
In 2022, ChemPartner PharmaTech Co, headquartered in CN, reported total carbon emissions of approximately 13,354,090 kg CO2e. The emissions breakdown includes about 19,472,490 kg CO2e from Scope 1 and 19,472,490 kg CO2e from Scope 2, while there were no reported emissions from Scope 3. Despite the significant emissions figures, ChemPartner has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of a climate pledge or science-based targets indicates a potential area for improvement in their sustainability strategy. As the pharmaceutical industry increasingly prioritises climate commitments, ChemPartner's current emissions data highlights the need for enhanced transparency and proactive measures to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 19,472,490 |
| Scope 2 | 19,472,490 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ChemPartner PharmaTech Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
